Clinical Update: Highly Treatment- Experienced Patients - Michael Kozal, MD

Global HIV Clinical Forum 2020

Clinical Case: Potential Challenges of Drug Interactions of Long-Acting Agents - Catia Marzolini, PharmD, PhD

Global HIV Clinical Forum 2020

HIV Prevention: The Second Wave of Choices - Richard Elion, MD

Global HIV Clinical Forum 2020

HIV Vaccines - Where Are We? - Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD

Global HIV Clinical Forum 2020

Therapeutic approaches for a sustainable remission and cure - Steven Deeks, MD

Global HIV Clinical Forum 2020

Starting Long-Acting Drugs in the COVID-19 Era - Anton Pozniak, MD, FRCP

Global HIV Clinical Forum 2020

Introducing New Therapies in Middle-Income Countries - Pedro Cahn, MD, PhD

Global HIV Clinical Forum 2020

Strategies for Management of Drug-Drug Interactions With Long-Acting Therapies - David Back, PhD

Global HIV Clinical Forum 2020

How and When to Monitor Patients On Long-Acting Antivirals? - Monica Gandhi, MD, MPH

Global HIV Clinical Forum 2020

Clinical Case: Reduced Drug Therapy - Mary Montgomery, MD

Global HIV Clinical Forum 2020

Implications for Women's Health - Sharon Walmsley, MD, FRCPC, CM

Global HIV Clinical Forum 2020

Implications for Sanctuary Sites and Drug Interactions - Marta Boffito, MD, PhD

Global HIV Clinical Forum 2020

Implications of Drug Resistance for the HIV Pandemic - Robert Shafer,MD

Global HIV Clinical Forum 2020

Long Acting Injectable Antiretroviral Therapy - Martin Markowitz, MD

Global HIV Clinical Forum 2020

First-Line Therapy for HIV Infection - David Wohl, MD

Global HIV Clinical Forum 2020

Update on COVID-19 in Persons with HIV Infection - Daniel Kuritzkes, MD

Global HIV Clinical Forum 2020